Aducanumab: A Deep Dive into BIIB037 and its Impact The compound, previously known as BIIB037, constitutes a notable effort to address emerging Alzheimer's condition. Developed by Biogen, the treatment works by https://rishigngj094046.pointblog.net/text-93297895